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SUMMARY. A simple and rapid procedure has been developed and validated for the simultaneous deter-
mination of benzoylecgonine and ecgonine methyl ester in human urine samples. After extraction and
sample cleanup by solid-phase extraction (SPE), the extracts were derivatized with 50 μL of MTBSTFA
and analyzed by gas chromatography/mass spectrometry (GC/MS). The limit of detection (LOD) was 50
ng/mL for both metabolites. The recoveries were 81% and 75.3% for benzoylecgonine and ecgonine
methyl ester, respectively. The intra-assay precision (% relative standard deviation) at two different
added amounts (200 and 1000 ng/mL) in urine matrix varied from 4.8 to 8.4 and from 4.4 to 5.7, respec-
tively. The mass spectra obtained for each compound have many diagnostics ions with relative abundance
in accordance with the WADA requirements.
